Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 21074262)

Published in Biomaterials on November 11, 2010

Authors

Francesca Colazzo1, Padmini Sarathchandra, Ryszard T Smolenski, Adrian H Chester, Yuan-Tsan Tseng, Jan T Czernuszka, Magdi H Yacoub, Patricia M Taylor

Author Affiliations

1: IRCCS Policlinico S. Donato, via Morandi 30, 20097, S. Donato Milanese, Milano, Italy.

Articles citing this

Adipose tissue: friend or foe? Nat Rev Cardiol (2012) 1.24

Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18

Mesenchymal stem cell responses to mechanical stimuli. Muscles Ligaments Tendons J (2012) 1.03

A cytokine axis regulates elastin formation and degradation. Matrix Biol (2012) 0.89

Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One (2014) 0.87

Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Transl Res (2011) 0.82

Artificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells. Tissue Eng Part A (2011) 0.80

Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices. Tissue Eng Part C Methods (2015) 0.79

Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications. Tissue Eng Part B Rev (2013) 0.78

A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions. J Biomech Eng (2014) 0.77

Optimizing Photo-Encapsulation Viability of Heart Valve Cell Types in 3D Printable Composite Hydrogels. Ann Biomed Eng (2016) 0.76

Assessment of Parylene C Thin Films for Heart Valve Tissue Engineering. Tissue Eng Part A (2015) 0.75

Articles by these authors

Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med (2006) 8.98

Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84

Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation (2011) 3.18

Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res (2002) 2.73

Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation (2007) 2.24

A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med (2008) 2.10

Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol (2003) 1.95

Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet (2010) 1.95

Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol (2009) 1.85

Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 1.84

Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J (2006) 1.78

The cardiac valve interstitial cell. Int J Biochem Cell Biol (2003) 1.76

Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation (2006) 1.75

Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol (2010) 1.72

Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol (2009) 1.65

The Ross procedure: a systematic review and meta-analysis. Circulation (2008) 1.65

Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging (2010) 1.61

Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng (2006) 1.57

Establishing pediatric cardiovascular services in the developing world: a wake-up call. Circulation (2007) 1.54

Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Transplantation (2010) 1.50

Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res (2006) 1.47

Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg (2003) 1.43

Bridge to recovery: what remains to be discovered? Cardiol Clin (2011) 1.42

C-type natriuretic peptide relaxes human coronary artery bypass grafts preconstricted by endothelin-1. Ann Thorac Surg (2005) 1.41

Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts. Transplantation (2002) 1.40

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2002) 1.39

Preserved homograft function 32 years after surgery in a young patient. J Thorac Cardiovasc Surg (2010) 1.38

Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J (2004) 1.38

Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37

Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36

Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater (2013) 1.34

Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A Mol Integr Physiol (2006) 1.30

Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart (2008) 1.29

Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol (2003) 1.28

Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res (2008) 1.28

Molecular and functional characteristics of heart-valve interstitial cells. Philos Trans R Soc Lond B Biol Sci (2007) 1.27

Revealing new mouse epicardial cell markers through transcriptomics. PLoS One (2010) 1.24

The structure and function of cardiac t-tubules in health and disease. Proc Biol Sci (2011) 1.23

Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun (2007) 1.23

Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism. PLoS Biol (2013) 1.18

Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg (2003) 1.17

Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ Res (2008) 1.17

The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials (2012) 1.16

Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg (2012) 1.15

Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis Model Mech (2013) 1.15

Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc Res (2010) 1.15

Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation (2002) 1.15

Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J (2004) 1.13

Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation (2004) 1.12

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol (2007) 1.12

Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation (2005) 1.10

Neglected diseases in cardiology: a call for urgent action. Nat Clin Pract Cardiovasc Med (2008) 1.10

Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation (2006) 1.10

Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng (2006) 1.10

Contemporary use of ventricular assist devices. Annu Rev Med (2010) 1.09

The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol (2004) 1.09

Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A (2004) 1.08

Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca(2+)-induced Ca(2+)release in a rodent model of heart failure. Eur J Heart Fail (2012) 1.08

Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation (2004) 1.08

Expression of follistatin-related genes is altered in heart failure. Endocrinology (2008) 1.07

Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol (2013) 1.07

Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering. J Mater Sci Mater Med (2007) 1.06

Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A (2009) 1.06

30-year outcome of anatomic correction of anomalous origin of the left coronary artery from the pulmonary artery. J Am Coll Cardiol (2011) 1.06

Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J (2004) 1.04

Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface. FASEB J (2010) 1.04

Erythrocyte-dependent regulation of human skeletal muscle blood flow: role of varied oxyhemoglobin and exercise on nitrite, S-nitrosohemoglobin, and ATP. Am J Physiol Heart Circ Physiol (2010) 1.04

Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation (2008) 1.04